Study

EORTC-1506-ANITA

A phase II multicenter study comparing the efficacy of the oral angiogenesis inhibitor nintedanib with the intravenous cytotoxic compound ifosfamide for treatment of patients with advanced metastatic soft tissue sarcoma after failure of systemic non-oxazaphosporine-based first line chemotherapy for inoperable disease "ANITA"

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 07-Jul-2017
Date Step1 close: 22-Nov-2019

Data management at EORTC

Yes

Design

Phase 2
Randomized open label

Targeted Sample size

EORTC Groups: 158 - All Groups: 158

Protocol summary

http://clinicaltrials.gov/study/NCT02808247

NCT number

NCT02808247

EudraCT

2016-002093-12